CBD Industry Soars in Wake of Farm Bill; Massive Growth Projected to Continue

CannabisNewsWire Editorial Coverage: Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.

  • Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
  • CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
  • This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Some companies are specializing in particular niches, such as The Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) with its focus on sustainable organic plants. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) is making moves into Europe, with cannabis oil sales in Germany and investment in a Portuguese grower. Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is launching new products and opening its own shops across the United States. And HEXO Corp. (NYSE: HEXO) (TSX: HEXO), which recently expanded from medical cannabis into…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Hemp Boom Leads to Cultivation Supply Shortages

CannabisNewsWire Editorial Coverage: The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers.

  • The growth of hemp more than doubled in the United States last year
  • More companies are moving to produce hemp, causing a surge in demand for cultivation and hydroponic supplies
  • Shortages are particularly acute relative to the hemp micropropagation and hemp cloning supplies as the spring planting season looms

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies. Tilray Inc. (NASDAQ: TLRY) has been expanding through the acquisition of other companies and a move into Europe, with a successful harvest in Portugal. Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) is using outside investment to expand from Canada to New York and to develop CBD-infused drinks. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has also seen substantial outside investment thanks to growing faith in hemp. Aphria Inc. (NYSE: APHA) (TSX: APHA) has even faced a hostile takeover attempt as some companies look for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Complaints about the Minnesota Medical Cannabis Task Force Increase

When Minnesota legalized medical cannabis in 2014, a task force was established to evaluate the medical cannabis program and report back to the state. However, numerous complaints about the operation and effectiveness of this task force have arisen.

Representatives of patients, law enforcement agencies, the medical community, lawmakers and other stakeholders make up this task force. The task force is mandated to scrutinize patient access to the medical marijuana program, the affordability of the products and any other issue connected to medical cannabis.

However, the task force appears to have been doomed right from its very inception. For example, the law establishing this entity wasn’t very clear on the exact duties of the task force.

Consequently, some of its members thought that the task force would assess the conditions that people wanted to be added to the list of qualifying conditions and then make recommendations on the same while other members didn’t think the task force had that authority.

Additionally, the composition of the task force appears not to be conducive for the group to do its work. This is because the task force has members who have divergent views about the appropriateness of having a medical cannabis program in the state.

Such divergent views of the proponents and opponents of the medical marijuana program create a lot of tension during meetings, so it is hard for the members to agree on anything.

As if the issues above weren’t bad enough, the task force rarely meets. For example, the last meeting they held was in 2017. It is nearly two years since they held a meeting!

Even the meetings that have been convened haven’t been well attended. Denis Flaherty, the ED of the Minnesota Police and Peace Officers Association, revealed as much when he decided to resign his membership on the task force.

He said that being on the task force was “a waste of my time” due to the poor attendance and the lack of impact that the meetings were having.

Because of the lack of impact by the task force, medical marijuana remains very expensive (and many patients have resorted to the black market).

These complaints about the task force haven’t gone unnoticed by the powers that be in the state. For example, Rep. Heather Edelson has drafted a bill to clarify how often the task force should meet, and the specific issues they should consider during that annual meeting.

Gov. Tim Walz also acknowledged that there were frustrations with the task force. He revealed that he was considering recreating the group into a new one that will consider the legalization of recreational marijuana in addition to assessing the medical cannabis program.

It seems there is all round consensus that something needs to be done to make the task force more useful. Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) call on all the concerned authorities to revisit the task force so that medical marijuana patients aren’t exposed to preventable inconveniences.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Two New Jersey Committees Voted on Marijuana Legalization Today

Two committees in the New Jersey Senate and Assembly voted on a bill to legalize recreational marijuana today (March 18). If the bill passed in both committees, then the entire House could vote on the matter as soon as March 25.

Stephen Sweeney, the Senate President, revealed that the members had received copies of the bill on Thursday last week and that the Democrats in the House have started talking to Republicans in order to get some of them to vote for the bill.

The support of some Republicans was crucial, because a number of prominent Democrats in the House were likely to vote against the bill. In order to pass, at least 21 Senators needed to vote for the bill.

The current bill is a modified form of the original version. The tax system suggested in the original version was changed so that marijuana could be taxed by weight instead of imposing an excise tax on every sale made.

The modified bill also has a provision to expunge the criminal record of individuals who were arrested or convicted for marijuana distribution. This didn’t exist in the previous version of the marijuana legalization bill.

It is this modified bill that the Senate Judiciary committee considered and voted on at 2:00 p.m. today, while the Appropriations Committee of the Assembly sat at noon today.

Marijuana proponents say they aren’t inventing marijuana. Rather, it is present in the different communities, and the social injustices committed during the so-called war on drugs also exist.

Passing the legalization bill would regulate the cannabis industry and get it out of the hands of criminal gangs. The state would earn taxes from the industry and thousands of jobs would be created. All this isn’t bad, the advocates say.

Another bill that was voted on today aims at increasing the quantity of medical cannabis that a patient can buy in the state. The bill also set in motion steps to end the imposition of excise tax on medical cannabis by 2024, in addition to legalizing marijuana edibles.

A third bill aims at making it easier for New Jersey to expunge marijuana charges from the criminal records of those who qualify under the law. For example, the mandatory time that must elapse before the charges are expunged will be reduced under this law.

This week may potentially be a turning point as far as marijuana is concerned in New Jersey. SinglePoint, Inc. (OTCQB: SING) and Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) called for an objective assessment of the bills before voting took place. Such a sober approach will ensure that the best decisions are made on behalf of the people of New Jersey.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Conference 2019 Expected to Attract More than 1,000 Growers and Marketers

If the attendance record of last year’s event is any guide, more than 1,000 cannabis cultivators, consultants, capital market pros, retailers and R&D professionals will assemble for the next-gen Cannabis Conference 2019 hosted by Cannabis Business Times and Cannabis Dispensary.

The three-day event will be held on April 1-3, 2019, at the Westgate Las Vegas Resort and Casino in…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWireText “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Drink Companies Prepare for the Coming of CBD Beverages

CannabisNewsWire Editorial Coverage: CBD-infused beverages look set to hit the market in a big way in 2019.

  • Cannabidiol (CBD) is widely used in health and wellness products after spectacular growth in recent years.
  • Several companies are lining up to launch CBD drinks following legal changes in the United States and Canada.
  • Integrating these new offerings into wider product lines is accelerating CBD’s race for mainstream attention.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is one of the first to launch, with a CBD coffee coming in May and a CBD water in the works. The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), which is constantly growing its U.S. distribution network, plans to add a CBD bottled water to its range. The New Age Beverages Corporation (NASDAQ: NBEV) is adding CBD to its line of organic cold coffees and teas. Heineken (OTCQX: HEINY) has also entered the market by developing a cannabis-infused sparkling water through Lagunitas, its U.S. craft brewer. And the biggest investment in the overall cannabis space has come from Constellation Brands Inc. (NYSE: STZ), which has invested…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – First Specialist Medical Marijuana Clinic Opens in the UK

Last Saturday (March 9) saw history being made in the UK as the first specialist medical cannabis clinic opened in Manchester. The clinic is called The Beeches Consulting Center.

The opening of this clinic has been widely welcomed by patients and clinicians in the UK. This cannabis clinic is owned by European Cannabis Holdings (ECH), a group of companies that plans to open many more such clinics across the UK.

The clinic will be headed by two respected professionals in the medical field. These are an independent pain specialist, Dr. David McDowell, and the second is a consultant neurologist, Professor Mike Barnes.

Dr. McDowell also holds the distinction of being the first specialist to issue a medical cannabis prescription in the UK when the British government enacted a law that made it possible for patients to access medical cannabis starting from December 1. 2018.

Forzana Nazir is one of the first patients that Dr. McDowell issued a medical cannabis prescription to. She is eternally grateful for this because she has been able to transition from taking 13 different medications for her genetic disorder to just three prescription medications ever since she started taking medical marijuana.

Nazir suffers from Ehlers Danlos Syndrome that made her nearly bedridden on a permanent basis due to the severe pain, vomiting and nausea. She credits medical marijuana for significantly improving her quality of life and also for weaning her off many prescription opioids.

The opportunities offered by this new clinic have huge significance given the difficulties that patients have been experiencing if they want to access medical cannabis through the NHS (National Health Service).

Patients are required to establish exceptional clinical circumstances, exhaust all the current treatment options available in the UK, get approval from an NHS Trust Medical Director and then get a medical specialist who is willing to accept liability for their medical cannabis treatment. Only then can a patient receive medical marijuana from the NHS. Any wonder that only four patients have so far accessed the NHS medical marijuana?

The clinic in Manchester, and others that will be opened, will offer an alternative to the complicated bureaucracy associated with getting medical marijuana through the NHS. For now, the clinic will treat chronic pain (due to arthritis, spasticity, fibromyalgia, etc.), psychiatric conditions (anxiety, depression, PTSD, etc.) and neurological conditions, such as Parkinson’s disease, Alzheimer’s, multiple sclerosis and epilepsy.

Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) congratulate ECH upon that major milestone of opening the first specialized medical marijuana clinic in the UK. That is a major investment which should open the eyes of other businesses to the massive opportunities that exist in the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – British Lawyers Head to Brussels Over CBD Ban

Last month, we reported that there was a run on CBD drinks and other CBD products in the UK after the EU declared that CBD and other cannabis or hemp extracts were novel foods that could only be allowed on the market after receiving regulatory approval. Cannabis industry players in the UK aren’t taking that ban lying down. Their association has instructed a team of lawyers to head to Brussels in order to try and overturn that ruling.

While the EU law, (EU) 2015/2283, isn’t binding on the member states, many countries use the guidance provided by the EU to draft their own domestic laws and regulations. Actually, many EU countries promptly act on those recommendations then ask questions later.

For example, Austria immediately banned CBD and all food products containing it as soon as the EU made its ruling on the products.

Cannabinoids were categorized as novel foods by the EU since industry players “failed to prove” that those products had a history of being consumed in the EU prior to 1997 when the European Food Safety Authority (EFSA) was established.

Mackrell Turner Garrett, a London-based law firm, together with a leading trading standards and food attorney in the UK, have been sent to Brussels to meet EFSA officials in order to argue the case of the CBD industry in the UK.

The lawyers are acting on behalf of the Cannabis Trade Association UK and they will try to convince EFSA at the EU headquarters that since hempseed and hempseed extracts have already been approved, then they don’t belong in the category of the novel foods that should be banned.

This will be a tough fight to complete because the EU has a history of being cautious regarding any major global developments with origins in North America. This pushback has particularly been strong ever since the financial meltdown of 2008.

But the team from London is unfazed and wants to argue the case of its members. CBD has grown so rapidly that in just three years, the CTA (Cannabis Trade Association) has grown to more than 700 members.

Additionally, the CBD industry contributes approximately $130 million to the British economy each year. It remains to be seen whether the arguments presented by the lawyers will change the minds of the regulators in Brussels. Medical Cannabis Payment Solutions (OTC: REFG), MustGrow Biologics Corp. and other people who see investment opportunities hope that Brussels changes its stand so that the growth of the industry isn’t torpedoed at this point.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Workers’ Compensation Being Modified to Incorporate Medical Cannabis in Canada

You would expect that with more than 17 years of existence in Canada, medical cannabis should have already led to policy changes in various aspects of life in the country. However, if the claims of injured workers are anything to go by, workers’ compensation guidelines have been slow in changing to accommodate this form of treatment. Now matters are beginning to shift as the discussion below shows.

More Workers Winning in Tribunals

Mellissa Ellsworth is just one of 10 patients who have won hearings in Nova Scotia’s workers’ comp tribunal set up to assess whether the Workers’ Compensation Board should cover the cost of medical marijuana. It took her five years to get this approval.

Alberta’s board has so far also accepted to cover the medical marijuana costs of 10 workers who were injured on the job. New Brunswick shines in this regard because it has so far approved 71 patients’ applications for medical cannabis costs coverage under workers’ comp policies.

It is saddening that patients have to endure years of pain as their applications slowly make their way through the red tape of the Workers’ Compensation Boards in the different provinces and territories. For example, the neurological pain experienced by Melissa Ellsworth led her to take a total of 26 pills on a daily basis just to function as a normal human. She now takes only cannabis and enjoys a better quality of life.

The good news amidst all this is that for each patient who gets approval, more are encouraged to table their requests before the different boards. Eventually, medical cannabis will become a normal form of treatment and no patient will have to go through what the pioneers like Melissa Ellsworth had to endure to get approval.

Doctors’ Prescriptions Rarely Considered

You would think that the different Workers’ Compensation Boards would attach some weight to the recommendations provided by the primary healthcare providers of the patients who apply for coverage.

However, only Quebec recognizes and acts upon those recommendations. Other boards convene their own medical team sittings to assess the eligibility of a patient for medical cannabis. Why should this happen when Health Canada screens patients before giving them a medical cannabis card?

Caps on Daily Cannabis Consumption

Nearly all provinces and territories that are even willing to consider paying for medical cannabis for injured workers impose a three gram cap on how much medical cannabis a patient can claim coverage for each day.

While there may be valid reasons for this cap, it would be reasonable for these boards to acknowledge that different patients have different needs, so mechanisms should be available for those who need more to be covered without major hassles. Even Health Canada allows patients to grow hundreds of cannabis plants if they need a lot on a daily basis for their treatment. But, workers’ comp boards still insist on three grams a day!

But, There’s Progress…

Amidst this huge cloud hovering over injured workers in Canada, winds of change are slowly picking up. Last year, New Brunswick set the stage by passing medical cannabis guidelines. Prince Edward Island followed suit, and now Nova Scotia is drafting its own set of guidelines.

While all this is happening in Canada, one wonders what the situation is here in the U.S. With most marijuana businesses still struggling to access banking services, it is hard to picture what patients may be going through if they wish to have their medical cannabis costs covered by workers’ comp insurance. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) decry the slow rate at which workers’ compensation is evolving to accommodate medical cannabis. This isn’t only denying patients a viable treatment option, but it is also limiting the investment opportunities that would boost the economy.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Demand Soars for Missouri Medical Cannabis Licenses

The cannabis bullet train doesn’t seem to be showing any signs of slowing down in Missouri ever since voters overwhelmingly passed a ballot measure in the recent midterms to legalize medical marijuana in the state. Now more than 300 businesses are due to be licensed to participate in the medical cannabis industry once it is commercialized.

This announcement was made by Lyndall Fraker, the Missouri Medical Marijuana Program Director, while speaking at a medical marijuana conference in St. Louis on Monday (March 11). He added that if those 300 licenses weren’t enough, then the state wouldn’t hesitate to grant more to the businesses that wish to serve Missouri patients in different capacities.

Already, more than 450 applications have been received from entities that would like to cultivate, manufacture, dispense or test medical marijuana and its products in the state. It is from this pool that the state will select the first 300 businesses to be licensed.

For now, the regulator has set the minimum number of players that will operate in the different segments of the medical marijuana industry. These include at least 192 dispensaries, two marijuana testing facilities, 85 manufacturing facilities and 60 marijuana cultivation facilities.

When added up, those figures exceed the 300 licenses that will be awarded initially, so you can see that the state already has plans for an extensive and robust medical cannabis industry.

You may be wondering, won’t 300 businesses be too many for an industry that is just being set up? This concern may be legitimate, but if anything is to be learnt from the Canadian recreational cannabis industry, it is risky to allow only a few players in the industry.

The cannabis shortages in Canada can largely be explained by the country’s failure to license enough businesses to participate in the different aspects of the cannabis value chain. The resulting mess will possibly take years to fix. Missouri may therefore be onto something when they start off with hundreds of licensed businesses.

Besides, not all of those 300 businesses will start operations at the same time. And when they do start, not all of them will be successful. Others will close shop while more will merge with other businesses.

It is therefore a good thing that the state intends to give all those businesses a shot and then their fate will be squarely in their hands once they get hold of a license. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), Green Hygienics Holdings Inc. (OTCQB: GRYN) and all who wish to invest in the medical cannabis industry welcome the steps being taken by the Missouri Medical Marijuana Program to do things right from the get-go.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com